Follicle-stimulating hormone and cancer
Cellular Signalling · 2026-11 · 147 · 112738
DOI: 10.1016/j.cellsig.2026.112738 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-11. Verfasst von Yaohua Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Lab…. Hauptthemen laut MEDLINE: Receptors, FSH, Follicle Stimulating Hormone, Neoplasms, Ovarian Neoplasms. Die Arbeit nennt 86 Literaturangaben. Gefördert von: Shandong Province Health Department.
Abstract (Originalsprache)
Follicle-stimulating hormone (FSH) and its receptor FSHR have traditionally been studied as regulators of reproductive physiology. Recent evidence indicates that FSH-FSHR signaling may be involved in selected cancer-related processes, but its effects are highly context dependent. This review grades evidence by tumor type and distinguishes tumor-cell FSHR from vascular FSHR, as these compartments have different mechanistic, biomarker and therapeutic implications. This review discusses evidence linking this axis to proliferation, epithelial-mesenchymal transition (EMT), metabolic remodeling, cancer stemness and metastasis, with particular emphasis on ovarian cancer and on contradictory or limited findings in other tumor types. This review also evaluates FSHR detection methods, biomarker interpretation, FSHR-targeted nanomedicine and imaging approaches, and safety concerns related to off-tumor binding and endocrine-related toxicity. Further standardization of FSHR detection, endocrine-context modeling and clinically defined validation cohorts is needed before FSHR-based strategies can be translated into routine cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Diseases & Shandong Engineering Research Center of Den…
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
- Department of Rehabilitation Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250012, China. Electronic address: zm17686689905@126.com.
Förderung
- Shandong Province Health Department
Zitieren
APA
Li, Y., Liu, Y., Guo, Y., Guo, M., Li, Z., Zheng, M., & Liu, G. (2026). Follicle-stimulating hormone and cancer. Cellular Signalling, 147, 112738. https://doi.org/10.1016/j.cellsig.2026.112738
Vancouver
Li Y, Liu Y, Guo Y, Guo M, Li Z, Zheng M, et al. Follicle-stimulating hormone and cancer. Cellular Signalling. 2026;147:112738. doi:10.1016/j.cellsig.2026.112738
BibTeX
@article{Li2026,
author = {Li, Yaohua and Liu, Yuexin and Guo, Yang and Guo, Mingzhang and Li, Zizhan and Zheng, Mei and Liu, Gangli},
title = {Follicle-stimulating hormone and cancer},
journal = {Cellular Signalling},
year = {2026},
volume = {147},
pages = {112738},
doi = {10.1016/j.cellsig.2026.112738}
}
EUVIMED